Global law firm Greenberg Traurig, P.A. advised OPKO Health Inc., a Miami-based multinational biopharmaceutical and diagnostics company, in the $237.5 million sale of select assets of its wholly owned subsidiary, Bioreference Health, to Labcorp.

The transaction, completed Sept. 16, is expected to provide patients, physicians, and customers with greater access to Labcorp’s services and expand testing capabilities in key regions nationally, according to Labcorp.

The deal includes BioReference Health’s reproductive and women’s health laboratory testing business in the United States, excluding New York and New Jersey. It includes certain patient service centers, customer contracts, and operating assets, which generate about $100 million in annual revenue.